![](/img/cover-not-exists.png)
Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment
McGowan, Ian, Dezzutti, Charlene S, Siegel, Aaron, Engstrom, Jarret, Nikiforov, Alexiy, Duffill, Kathryn, Shetler, Cory, Richardson-Harman, Nicola, Abebe, Kaleab, Back, David, Else, Laura, Egan, DeidrLanguage:
english
Journal:
The Lancet HIV
DOI:
10.1016/S2352-3018(16)30113-8
Date:
September, 2016
File:
PDF, 587 KB
english, 2016